Evinacumab Across Different Lipid Phenotypes: A Systematic Review and Meta-Analysis.
INTRODUCTION Evinacumab, a monoclonal antibody targeting angiopoietin-like protein 3 (ANGPTL3), has emerged as a promising therapeutic option for severe dyslipidemias. We have conducted a systematic review to evaluate its efficacy across different clinical settings. METHODS This systematic review and meta-analysis wa...